These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 11239907)

  • 1. Reactivity of serotonin in whole blood: relationship with drug response in obsessive-compulsive disorder.
    Humble M; Bejerot S; Bergqvist PB; Bengtsson F
    Biol Psychiatry; 2001 Feb; 49(4):360-8. PubMed ID: 11239907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma oxytocin changes and anti-obsessive response during serotonin reuptake inhibitor treatment: a placebo controlled study.
    Humble MB; Uvnäs-Moberg K; Engström I; Bejerot S
    BMC Psychiatry; 2013 Dec; 13():344. PubMed ID: 24359174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
    Pigott TA; Seay SM
    J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of serotonin release in the guinea pig orbito-frontal cortex by selective serotonin reuptake inhibitors. Relevance to treatment of obsessive-compulsive disorder.
    el Mansari M; Bouchard C; Blier P
    Neuropsychopharmacology; 1995 Oct; 13(2):117-27. PubMed ID: 8597523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tryptophan depletion on selective serotonin reuptake inhibitor-remitted patients with obsessive compulsive disorder.
    Hood SD; Broyd A; Robinson H; Lee J; Hudaib AR; Hince DA
    J Psychopharmacol; 2017 Dec; 31(12):1615-1623. PubMed ID: 29095069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of response to paroxetine and venlafaxine by serotonin-related genes in obsessive-compulsive disorder in a randomized, double-blind trial.
    Denys D; Van Nieuwerburgh F; Deforce D; Westenberg HG
    J Clin Psychiatry; 2007 May; 68(5):747-53. PubMed ID: 17503984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double blind comparison of venlafaxine and paroxetine in obsessive-compulsive disorder.
    Denys D; van der Wee N; van Megen HJ; Westenberg HG
    J Clin Psychopharmacol; 2003 Dec; 23(6):568-75. PubMed ID: 14624187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paroxetine in the treatment of obsessive-compulsive disorder: randomized, double-blind, placebo-controlled study in Japanese patients.
    Kamijima K; Murasaki M; Asai M; Higuchi T; Nakajima T; Taga C; Matsunaga H
    Psychiatry Clin Neurosci; 2004 Aug; 58(4):427-33. PubMed ID: 15298657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder.
    Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L
    Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine.
    Rosenberg DR; MacMaster FP; Keshavan MS; Fitzgerald KD; Stewart CM; Moore GJ
    J Am Acad Child Adolesc Psychiatry; 2000 Sep; 39(9):1096-103. PubMed ID: 10986805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obsessive-compulsive disorder: implications of the efficacy of an SSRI, paroxetine.
    Ninan PT
    Psychopharmacol Bull; 2003; 37 Suppl 1():89-96. PubMed ID: 14566204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivity of serotonin in whole blood.
    Mulder EJ; Anderson GM; Kema IP; Minderaa RB
    Biol Psychiatry; 2002 Feb; 51(3):266-8. PubMed ID: 11839371
    [No Abstract]   [Full Text] [Related]  

  • 13. Obsessive-compulsive spectrum disorders: effective treatment with paroxetine.
    Ravindran AV; Lapierre YD; Anisman H
    Can J Psychiatry; 1999 Oct; 44(8):805-7. PubMed ID: 10566112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators.
    Zohar J; Judge R
    Br J Psychiatry; 1996 Oct; 169(4):468-74. PubMed ID: 8894198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sumatriptan, 5-HT(1D) receptors and obsessive-compulsive disorder.
    Koran LM; Pallanti S; Quercioli L
    Eur Neuropsychopharmacol; 2001 Apr; 11(2):169-72. PubMed ID: 11313163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and long-term treatment and prevention of relapse of obsessive-compulsive disorder with paroxetine.
    Hollander E; Allen A; Steiner M; Wheadon DE; Oakes R; Burnham DB;
    J Clin Psychiatry; 2003 Sep; 64(9):1113-21. PubMed ID: 14628989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case study: caudate glutamatergic changes with paroxetine therapy for pediatric obsessive-compulsive disorder.
    Moore GJ; MacMaster FP; Stewart C; Rosenberg DR
    J Am Acad Child Adolesc Psychiatry; 1998 Jun; 37(6):663-7. PubMed ID: 9628087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials.
    Dold M; Aigner M; Lanzenberger R; Kasper S
    Int J Neuropsychopharmacol; 2015 May; 18(9):. PubMed ID: 25939614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial.
    Dannon PN; Sasson Y; Hirschmann S; Iancu I; Grunhaus LJ; Zohar J
    Eur Neuropsychopharmacol; 2000 May; 10(3):165-9. PubMed ID: 10793318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression.
    Saxena S; Brody AL; Ho ML; Zohrabi N; Maidment KM; Baxter LR
    Am J Psychiatry; 2003 Mar; 160(3):522-32. PubMed ID: 12611834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.